A “micro-tap” for treating glaucoma

Share via AddThis
Posted on March 26, 2013

A tiny, EPFL-designed implantable device that can be positioned within the eye and controlled remotely may well revolutionize the treatment of glaucoma. The device should be through testing this year and on its way to the market in 2014 via Rheon Medical, an EPFL spin-off.

Glaucoma is the second leading cause of blindness globally, after cataracts. It is characterized by the presence of too much liquid between the cornea and the iris. This leads to a build-up of pressure within the eye, a situation that can destroy the optic nerve if it is not handled correctly.

Read more at: EPFL



40,185 science & technology articles

Categories

Our Articles (see all)

General News

Follow us

Facebook   Twitter   Pinterest   StumbleUpon   Plurk
Google+   Tumblr   Delicious   RSS   Newsletter via Email

Featured Video (see all)

Dark matter can be observed by analyzing distribution of regular matter and its gravitational interactions in large-scale objets, such as galaxies. Image source: YouTube screenshot.
Complex dark matter
In this video, U.S. CMS Education and Outreach Coordinator Don Lincoln discusses how dark matter might have a…

Featured Image (see all)


Multi-Utility Technology Testbed Aircraft On the Runway
The X-56A Multi-Utility Technology Testbed (MUTT) is greeted on an Edwards Air Force Base runway by a U.S.…